Patent · US Active

Hemostatic compositions for arresting blood flow from an open wound or surgical site

US8110208B1 · kind B1 · utility

1,324Cited by
29References
7Claims
0Family size

Assignee

Inventor

Key dates

Filing dateMar 29, 2010
Grant dateFeb 7, 2012
Priority date
Expiry dateJul 16, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L2400/04
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

A hemostatic composition for stopping or decreasing blood flow from an open wound or medical or surgical procedure. Compositions of the invention comprise a mixture of a cationic polymer and a cation exchange material. In one embodiment, the composition comprises a mixture: (1) a high molecular weight copolymer of diallyl dimethyl ammonium chloride (DADMAC) and acrylamide [DADMAC copolymer], and (2) the hydrogen form of a crosslinked, sulfonated polystyrene (hydrogen resin). In an exemplified embodiment, a composition of the invention comprises the mixture of DADMAC copolymer and hydrogen resin provided in a dry powdered form. The compositions of the invention may be applied directly to a wound or treatment site, or they may be incorporated into a wound dressing, such as a bandage. The seal formed at a wound or treatment site treated with the present invention is adhesive and exhibits considerable toughness.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.